Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
about
Solving the puzzle of autoimmunity: critical questionsFeasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosisEnhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosisBaseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients.Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.Identifying Multi-Dimensional Co-Clusters in Tensors Based on Hyperplane Detection in Singular Vector Spaces.The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Role of toll-like receptors in multiple sclerosis.MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patientsMultiple sclerosis treatment and infectious issues: update 2013.Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.[Immunotherapy and infectious issues in multiple sclerosis. Self-injectable and oral drugs for immunotherapy].Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
P2860
Q28084677-48A1BD2D-B04E-4E0C-ACD5-A1DB2A37C126Q28535303-CC8A1DEB-665F-401D-9E95-7F562525B8F0Q34355672-9FE37D12-924A-4BF9-A6F7-E4B08278490FQ34513928-BC43D889-0546-464C-8ECF-567F28EE7AC2Q34947419-B8787492-7CB5-4528-8A4D-C4D71946F2B7Q35568496-6DBF98A8-C2CE-413F-97CE-5495C5291AD2Q36123914-000A9D6D-FBB4-40CC-ADDB-FA06B77BA7BBQ36338717-0E932DE1-718F-49C7-888A-7FA50ACEE045Q37021687-5491048A-3A67-4075-8CEB-A7889DFD4B87Q37139127-66B87510-83E8-4CB8-8ED8-858239398642Q38153471-FED20DBB-F7CD-4BD6-BC78-4553D9268D9FQ38687394-A75EF8C8-FB87-4706-9FC8-77F57F73D0A9Q39130808-0288E59C-0B20-49E1-A09E-CD22A30C75B1Q41102110-48AC789B-FDB9-4972-AF72-DAE245C3D31FQ51025796-07EB1220-8197-4F51-AC28-145A5E109012Q53178623-E785F3E2-1C6C-4F03-9432-0C7BE7FC0241
P2860
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Elevated type I interferon-lik ...... basis and clinical relevance.
@ast
Elevated type I interferon-lik ...... basis and clinical relevance.
@en
type
label
Elevated type I interferon-lik ...... basis and clinical relevance.
@ast
Elevated type I interferon-lik ...... basis and clinical relevance.
@en
prefLabel
Elevated type I interferon-lik ...... basis and clinical relevance.
@ast
Elevated type I interferon-lik ...... basis and clinical relevance.
@en
P2093
P2860
P356
P1476
Elevated type I interferon-lik ...... basis and clinical relevance.
@en
P2093
Alexander Hundeshagen
Brigitte Katrin Paap
Charlotte Angerstein
Christian Fatum
Christiane Hartmann
Dirk Koczan
Hans-Juergen Thiesen
Michael Hecker
Ole Kandulski
Uwe Klaus Zettl
P2860
P2888
P356
10.1186/1742-2094-9-140
P577
2012-06-22T00:00:00Z
P5875
P6179
1052495010